medigraphic.com
ISSN 2305-7939 (Electronic)

2012, Number 1

<< Back Next >>

RCU 2012; 1 (1)

Uso de hemoderivados en la cirugía mayor electiva

Muradás AM, Pérez DY, Sotolongo MY, Sanchez TR

Language: Spanish
References: 34
Page: 16-28
PDF size: 415.68 Kb.


ABSTRACT

Introduction: the current knowledge about the complications associated with the transfusional therapy, the individual adaptability to acute anemia and tisular oxygenation makes the enclosed employment of these therapies more and more restrictive in emergency situations like acute transoperative bleeding. Objectives: to determine the frequency of use and the quantity of transoperative hemoderivates in the major elective renal surgery in our institution, to indicate the transfusional threshold and the tranfusional complications observed. Methods: an observational and descriptive study was realized, of retrospective cohort. The study universe was constituted by the 571 patients who were operated of major elective renal surgery in our institution in the period earlier specified. Results: were studied 571 patients, from whom 59 (10.33 %) received hemoderivates transfusion. Feminine sex predominated and patients of white race with average age of 48.7 years. The most frequent illness was the arterial hypertension (20.8 %), the tabaquism was the only toxic habit analyzed in our study. We present a tendency to diminish the frequency of use of hemoderivates in our patients and therefore the annual consumption of the same ones, the transfusional threshold ranged between 22.5 vol. % and 25 vol. % of hematocrit, the allergic reactions were the only complications observed in 5 % of our sample. Conclusions: the use of a restrictive transfusional therapy, as well as the acceptance of a low transfusional threshold has allowed us to diminish the transfusion of homologous blood in our renal surgical patients and the frequency (5 %) of transfusional complications.


REFERENCES

  1. Goodnough LT, Shander A, Spence R. Bloodless medicine: Clinical care without allogenic blood transfusion. Transfusion 2003;43:668-76.

  2. Kickler TS. Why "bloodless medicine" and how should we do it? Transfusion. 2003;43(5):550-1.

  3. Van der Linden P. Editorial. Can. J. Anesth. 2003; 50(6)51-2.

  4. Transfusion Medicine. First of two Parts. Blood Transfusion. The N Eng J Medicine1999;340(6):438-46.

  5. Transfusion Medicine. Second of two parts. Blood conservation. The N Eng J Medicine1999, Feb 18;340(7):525-32.

  6. Otalza F. Situación de los bancos de sangre y medicina transfusional en Chile 1997. República de Chile. Ministerio de Salud. División de salud de las personas. Unidad de medicina transfusional.

  7. Schmunis GA, Zicker F, Pinheiro F, Brandling-Bennett D. Risk for transfusion-transmitted infectious diseases in Central and South America. Emerging infectious diseases. 1998;4(1):5.

  8. Houbiers JGA, Brand A, Van De Watering LMG, van de Velde CJH, Hermans J, Verwey PJM, et al. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. The Lancet. 1994;344(8922):573-8.

  9. Heiss MM, Mempel W, Jauch KW. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancer 1992;342:1328-33.

  10. Jensen IS, Andersen AJ, Christiansen PM. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br. J Surg 1992;79:513-6.

  11. Morgan GE, Mikhail MS, Murray MJ. Fluid management and transfusion. En: Morgan GE. Clinical Anesthesiology. McGraw-Hill. Fourth edition. 2006.

  12. Miller RD. Transfusion therapy. En: Miller RD. Anesthesia. Churchill Livingstone Inc. New York. Fourth edition. 1994.

  13. Hansell DM, Allain RM. Terapia transfusional. En: Hurford WE, Bailin MT, Davison JK, Haspel KL, Rosow C. Massachussets general Hospital. Procedimientos en Anestesia. Madrid, España. Marbán Libros S.L.5ta ed. 1999.

  14. Linden JV, Paul B, Dressler KP. A report of 104 transfusions errors in New York State. Transfusion 1992;32:601-606.

  15. Linden JV, Wagner K, Voytovich AE, Sheehan J. Transfusión errors in New Cork State; an análisis of 10 years' experience. Transfusión 2000;40:1207-1213.

  16. Benson AB, Moss M, Silliman C. Transfusion-related acute lung ingury (TRALI): A clinical revew with enphasis on the critically ill. BJH 2009; 147(4):431-43.

  17. Practice Guidelines for perioperative blood transfusion and adjuvant therapies. Anestesiology 2006;105:198-208.

  18. Despertad. Agosto2006. Watch Tower Bible and tract Society of Pennsylvania.

  19. Costituzione della Repubblica Italiana. Gazzetta Ufficiale Nº 298; 27 dicembre 1947.

  20. The Royal College of Surgeons of England. Code of Practice for the surgical management of Jehovah's witnesses. London: The Royal College of Surgeons of England; 2002.

  21. The Association of Anaesthetists of Great Britain and Ireland. Management of anaesthesia for Jehovah's Witness. London: The Association of Anaesthetists of Great Britain and Ireland; 1999.

  22. Constitution of the United States. National Archives. Washington, D.C.; September 17, 1987.

  23. Rouge-Maillart C, Jousset J, Gaches T, Gaudin A, Penneau M. Patients refusing medical attention: the case of Jehovah's Witnesses in France. Med Law 2004;23(4):715-23.

  24. Ariga T, Hayasaki S. Medical, legal and ethical considerations concerning the choice of bloodless medicine by Jehovah's Witnesses. Leg Med (Tokio) 2003; 5Suppl 1:S72-75.

  25. Retamales A. Autonomía del paciente: ejemplo de los Testigos de Jehová. Rev. Chil Cir. 2003;55(5):537-42.

  26. Hoffman C. Cirugía sin transfusión en Costa Rica. Rev. Hospital Clínico Universidad de Chile. 2000;11(4)145-49.

  27. Toriello L. Medicina transfusional en Chile. Rev. Hospital Clínico Universidad de Chile. 2000;11(4)150-56.

  28. Hebert PC, Yetisir E, Martin C, Blajchman MA, Wells G, Marshall J, et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med 2001;29(2):227-34.

  29. Carson JL, Ferreira G. Transfusion triggers: how low can we go? Vox Sang 2004;87(2):218-21.

  30. Viele MK, Weiskopf RB. What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah's Witnesses. Transfusion 1994;34(5):396-401.

  31. Weiskopf RB, Viele MK, Feiner J, Kelley S, Lieberman J, Noorani M, et al. Human cardiovascular and metabolic response to acute, severe isoVol.emic anemia. JAMA 1998;279(3):217-21.

  32. Asociación Argentina de Hemoterapia e Inmunohematología. 2007;XXXlll(3-4):205-232.

  33. Spence R., Parce P, Rase L, Popovky HA. Red blood cells transfusión to a hemoglobina of 10 g/dl. Does not improve survival in non cardiac, elective surgical patients. An analysis of 117,418 patients. Transfusion 2008; Vol. 48 suppl.

  34. Bernard AC, Davenport DL, Chang PK, Vaughan TB, Zwischenberger JB. Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. Journal of the American College of Surgeons. 2009;208(5):931-7.




2020     |     www.medigraphic.com